Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 10 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NATIONAL PATENT DEVELOPMENT CORP | 458,971 | reported | 22 Oct 2018 | tx 17+418,971 |
| Fluent, Inc. | 90,341 | reported | 18 Jun 2025 | tx 4+236,496 |
| OPKO HEALTH, INC. | 60,000 | reported | 23 Apr 2025 | tx 41+855,000−120,000 |
| BioCardia, Inc. | 48,845 | reported | 31 Dec 2020 | tx 20+385,458−19,005 |
| GeneDx Holdings Corp. | 41,506 | reported | 18 Jun 2025 | tx 20+508,600−50,891 |
| Cocrystal Pharma, Inc. | 16,410 | reported | 09 Jan 2026 | tx 8+261,810 |
| CONTINUCARE CORP | 0 | reported | 04 Oct 2011 | tx 35+2,702,520−4,390,000 |
| IVAX CORP | 0 | reported | 26 Jan 2006 | tx 4−247,893 |
| CELLULAR TECHNICAL SERVICES CO INC | 0 | reported | 22 Aug 2024 | tx 28+768,584−189,417 |
| GP STRATEGIES CORP | 0 | reported | 14 Oct 2021 | tx 65+50,297−56,297 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Jan 2026 | GRANT_AWARD | Cocrystal Pharma, Inc. | 16,410 | 0.00 USD | deriv |
| 28 Oct 2025 | GRANT_AWARD | Cocrystal Pharma, Inc. | 20,000 | — | |
| 28 Oct 2025 | GRANT_AWARD | Cocrystal Pharma, Inc. | 40,000 | 1.39 USD | deriv |
| 18 Jun 2025 | GRANT_AWARD | Fluent, Inc. | 39,682 | 0.00 USD | |
| 18 Jun 2025 | EXERCISE | GeneDx Holdings Corp. | 12,924 | 0.00 USD | |
| 18 Jun 2025 | GRANT_AWARD | GeneDx Holdings Corp. | 3,576 | 0.00 USD | deriv |
| 18 Jun 2025 | EXERCISE | GeneDx Holdings Corp. | 12,924 | 0.00 USD | deriv |
| 02 May 2025 | EXERCISE | GeneDx Holdings Corp. | 918 | 0.00 USD | |
| 02 May 2025 | EXERCISE | GeneDx Holdings Corp. | 918 | 0.00 USD | deriv |
| 23 Apr 2025 | GRANT_AWARD | OPKO HEALTH, INC. | 60,000 | 0.00 USD | deriv |
| 09 Oct 2024 | GRANT_AWARD | Cocrystal Pharma, Inc. | 8,067 | — | |
| 22 Aug 2024 | OTHER | CELLULAR TECHNICAL SERVICES CO INC | 189,417 | — | |
| 05 Jun 2024 | GRANT_AWARD | Fluent, Inc. | 21,429 | 0.00 USD | |
| 26 Jun 2024 | GRANT_AWARD | GeneDx Holdings Corp. | 12,924 | 0.00 USD | deriv |
| 20 Jun 2024 | EXERCISE | GeneDx Holdings Corp. | 5,828 | 0.00 USD | |
| 20 Jun 2024 | EXERCISE | GeneDx Holdings Corp. | 5,828 | 0.00 USD | deriv |
| 02 May 2024 | EXERCISE | GeneDx Holdings Corp. | 918 | 0.00 USD | |
| 02 May 2024 | EXERCISE | GeneDx Holdings Corp. | 918 | 0.00 USD | deriv |
| 05 Jan 2024 | PURCHASE | OPKO HEALTH, INC. | 13,000 | 0.93 USD | |
| 05 Jan 2024 | PURCHASE | OPKO HEALTH, INC. | 12,000 | 0.95 USD | |
| 13 Nov 2023 | PURCHASE | OPKO HEALTH, INC. | 10,000 | 1.30 USD | |
| 13 Nov 2023 | PURCHASE | OPKO HEALTH, INC. | 5,000 | 1.30 USD | |
| 13 Nov 2023 | PURCHASE | OPKO HEALTH, INC. | 5,000 | 1.30 USD | |
| 13 Nov 2023 | PURCHASE | OPKO HEALTH, INC. | 5,000 | 1.30 USD | |
| 08 Nov 2023 | PURCHASE | GeneDx Holdings Corp. | 10,000 | 1.49 USD |
4 purchases reported after at least 12 months of silence — most recent on 18 May 2023.